Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Chao, Mark P., Jaiswal, Siddhartha, Weissman-Tsukamoto, Rachel, Alizadeh, Ash A., Gentles, Andrew J., Volkmer, Jens, Weiskopf, Kipp, Willingham, Stephen B. +4 more·2010·Science Translational Medicine
DOI 10.1126/scitranslmed.3001375

Cited by (779)

Items 101–200 of 779

  1. Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer
    Fucikova, Jitka, Moserova, Irena, Urbanova, Linda, Bezu, Lucillia, Kepp, Oliver, Cremer, Isabelle, Salek, Cyril, Strnad, Pavel, Kroemer, Guido, Galluzzi, Lorenzo et al. · 2015 · Frontiers in Immunology
  2. Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
    Zahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, Ali Baradaran, Ali Mohammadi, Khalil Hajiasgharzadeh, Afshin Derakhshani, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran · 2020 · Cancers
  3. Programmed cell removal by calreticulin in tissue homeostasis and cancer
    Mingye Feng, Kristopher David Marjon, Fangfang Zhu, Rachel Weissman-Tsukamoto, Aaron Levett, Katie Sullivan, Kevin Shuolong Kao, Maxim Markovic, Paul A. Bump, Hannah M. Jackson et al. · 2018 · Nature Communications
  4. Non-thermal plasma induces immunogenic cell deathin vivoin murine CT26 colorectal tumors
    Abraham G. Lin, Bo Xiang, Dante J. Merlino, Trevor R. Baybutt, Joya Sahu, Alexander Fridman, Adam Eugene Snook, Vandana Miller · 2018 · OncoImmunology
  5. Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
    Robin Maximilian Awad, Yannick De Vlaeminck, Johannes Maebe, Cleo Goyvaerts, Karine Breckpot · 2018 · Frontiers in Immunology
  6. Primary phagocytosis of viable neurons by microglia activated with LPS or Aβ is dependent on calreticulin/LRP phagocytic signalling
    Michael Fricker, Maria José Oliva-Martín, Guy Charles Brown · 2012 · Journal of Neuroinflammation
  7. CD47–SIRPα-targeted therapeutics: status and prospects
    Roy L. Maute, Jianqing Xu, Irving L. Weissman · 2022 · Immuno-Oncology Technology
  8. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis
    Kojima, Yoko, Downing, Kelly, Kundu, Ramendra, Miller, Clint, Dewey, Frederick, Lancero, Hope, Raaz, Uwe, Perisic, Ljubica, Hedin, Ulf, Schadt, Eric et al. · 2014 · Journal of Clinical Investigation
  9. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell–Mediated Killing
    Sofia R. Gameiro, Anthony S. Malamas, Michael B. Bernstein, Kwong Yok Tsang, April Vassantachart, Narayan Sahoo, Ramesh C. Tailor, Rajesh Pidikiti, Chandan Guha, Stephen M. Hahn et al. · 2016 · International Journal of Radiation Oncology*Biology*Physics
  10. Anticancer metal drugs and immunogenic cell death
    Alessio Terenzi, Christine Pirker, Bernhard K. Keppler, Walter Berger · 2016 · Journal of Inorganic Biochemistry
  11. Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells
    Zhen Bian, Lei Shi, Ya-Lan Guo, Zhiyuan Lv, Cong Tang, Shuo Niu, Alexandra Tremblay, Mahathi Venkataramani, Courtney D Culpepper, Limin Li et al. · 2016 · Proceedings of the National Academy of Sciences
  12. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
    Flavia Radogna, Marc F. Diederich · 2018 · Biochemical Pharmacology
  13. Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity
    Valerie R. Wiersma, Marek Michalak, Trefa Mohammed Abdullah, Edwin Bremer, Paul Eggleton · 2015 · Frontiers in Oncology
  14. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo–immunotherapy
    Mingxia Jiang, Jun Zeng, Liping Zhao, Mogen Zhang, Jinlong Ma, Xiuwen Guan, Weifen Zhang · 2021 · Nanoscale
  15. Engineered CD47 protects T cells for enhanced antitumour immunity
    Sean A. Yamada‐Hunter, Johanna Lena Theruvath, Brianna J. McIntosh, Katherine A. Freitas, Frank H. S. Lin, Molly Radosevich, Amaury Leruste, Shaurya Dhingra, Naiara Martínez-Vélez, Peng Xu et al. · 2024 · Nature
  16. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
    Fucikova, Jitka, Truxova, Iva, Hensler, Michal, Becht, Etienne, Kasikova, Lenka, Moserova, Irena, Vosahlikova, Sarka, Klouckova, Jana, Church, Sarah E., Cremer, Isabelle et al. · 2016 · Blood
  17. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
    Abhishek Dinkarnath Garg, Erminia Romano, Nicole Rufo, Patrizia Agostinis · 2016 · Cell Death and Differentiation
  18. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: an update review
    Zhai, Jiaqi, Gu, Xi, Liu, Yang, Hu, Yueting, Jiang, Yi, Zhang, Zhenyong · 2023 · Frontiers in Pharmacology
  19. A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis
    Ferenc A. Scheeren, Angera H. Kuo, Linda J. van Weele, Shang Cai, Iris E. Glykofridis, Shaheen S. Sikandar, Maider Zabala, Dalong Qian, Jessica S. Lam, Darius M. Johnston et al. · 2014 · Nature Cell Biology
  20. Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
    Rosalynd Upton, Allison M. Banuelos, Dongdong Feng, Tanuka Biswas, Kevin Shuolong Kao, Kelly Marie McKenna, Stephen B. Willingham, Po Yi Ho, Benyamin Rosental, Michal Caspi Tal et al. · 2021 · Proceedings of the National Academy of Sciences
  21. Cell death by phagocytosis
    Brown, Guy C. · 2024 · Nature Reviews Immunology
  22. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
    Barbara Montico, Annunziata Nigro, Vincenzo Casolaro, Jessica Dal Col · 2018 · International Journal of Molecular Sciences
  23. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
    Daan C.H. van Dorst, Stephen J.H. Dobbin, Karla Bianca Neves, Joerg Herrmann, Sandra M. Herrmann, Jorie Versmissen, Ron H.J. Mathijssen, A.H. Jan Danser, Ninian N. Lang · 2021 · Circulation Research
  24. The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target
    Chris H.M. Takimoto, Mark Ping Chao, C. Gibbs, Mark A. Mccamish, J. Liu, James Y. Chen, Ravindra Majeti, Irving L. Weissman · 2019 · Annals of Oncology
  25. Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion
    Xiaojuan Liu, Longchao Liu, Zhenhua Ren, Kaiting Yang, Hairong Xu, Yan Luan, Kai Fu, Jingya Guo, Hua Peng, Mingzhao Zhu et al. · 2018 · Cell Reports
  26. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy
    Qianqian Mao, Juan Min, Rui Zeng, Haiqin Liu, Hao Li, Cao Zhang, Aixian Zheng, Jiumao Lin, Xiaolong Liu, Ming‐Hsun Wu · 2022 · Theranostics
  27. Functional Roles of Calreticulin in Cancer Biology
    Yi-Chien Lu, Wen‐Chin Weng, Hsinyu Lee · 2015 · BioMed Research International
  28. Glioblastoma hijacks microglial gene expression to support tumor growth
    Sybren L. N. Maas, Erik R. Abels, Lieke L. van de Haar, Xuan Zhang, Liza M. Morsett, Srinjoy Sil, Joana Ribeiro Guedes, Pritha Sen, Shilpa Prabhakar, Suzanne E. Hickman et al. · 2020 · Journal of Neuroinflammation
  29. CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
    Hongfei Wang, Yixuan Sun, Xiuman Zhou, Chunxia Chen, Ling Jiao, Wanqiong Li, Shanshan Gou, Yanying Li, Jiangfeng Du, Guanyu Chen et al. · 2020 · Journal for ImmunoTherapy of Cancer
  30. Immunosuppression by Mutated Calreticulin Released from Malignant Cells
    Peng Liu, Liwei Zhao, Friedemann Loos, Caroline Marty, Wei Xie, Isabelle Martins, Sylvie Lachkar, Bo Qu, Emmanuelle Waeckel-Énée, Isabelle Plo et al. · 2019 · Molecular Cell
  31. Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies
    E. Christine Pietsch, J Dong, R Cardoso, Xiaomin Zhang, Diana Chin, Rebecca Hawkins, T Dinh, M Zhou, Brandy Strake, P-H Feng et al. · 2017 · Blood Cancer Journal
  32. Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
    Mahiuddin Ahmed, Ming Huei Cheng, Qi Zhao, Yehuda Goldgur, Sarah M. Cheal, Hong-Fen Guo, Steven M. Larson, Nai‐Kong V. Cheung · 2015 · Journal of Biological Chemistry
  33. SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors
    Cory M. Alvey, Kyle R. Spinler, Jerome Irianto, Charlotte R. Pfeifer, Brandon H. Hayes, Yuntao Xia, Sangkyun Cho, P.C. Dave P. Dingal, Jake Hsu, Lucas Smith et al. · 2017 · Current Biology
  34. Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure–function
    AbdelAziz R. Jalil, Jason C. Andrechak, Dennis E. Discher · 2020 · Antibody Therapeutics
  35. Trial watch
    Erika Vacchelli, Lorenzo Galluzzi, Wolf H. Fridman, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Guido Kroemer · 2012 · OncoImmunology
  36. The Phagocytic Code Regulating Phagocytosis of Mammalian Cells
    Tom O. J. Cockram, Jacob M. Dundee, Alma S. Popescu, Guy Charles Brown · 2021 · Frontiers in Immunology
  37. Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses
    Tangsheng Yi, Jianhua Li, Hsin Chen, Jiaxi Wu, Jinping An, Ying Xu, Yongmei Hu, Clifford A. Lowell, Jason G. Cyster · 2015 · Immunity
  38. Advances in Therapeutic Cancer Vaccines
    Karrie Ka Wai Wong, Aileen W. Li, David J. Mooney, Glenn Dranoff · 2016 · Advances in immunology
  39. Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling
    Shaojun Pan, Yuhui Zhang, Mark Huang, Zhoufeng Deng, Amin Zhang, Lijia Pei, Lirui Wang, Weiyong Zhao, Lijun Ma, Qian Zhang et al. · 2021 · Biomaterials
  40. Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
    Linlin Ma, Min Zhu, Junwei Gai, Guanghui Li, Qing Hua Chang, Qiao Peng, Long‐Long Cao, Wanqing Chen, Siyuan Zhang, Yakun Wan · 2020 · Journal of Nanobiotechnology
  41. Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
    Robert William Lentz, Meryl D. Colton, Siddhartha S. Mitra, Wells A. Messersmith · 2021 · Molecular Cancer Therapeutics
  42. Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing
    Patrizia Leone, Simona Berardi, Maria Antonia Frassanito, Roberto Ria, Vallì De Re, Sebastiano Cicco, Stefano Battaglia, Paolo Ditonno, Franco Dammacco, Angelo Vacca et al. · 2015 · Blood
  43. Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
    Feng Li, Bingke Lv, Yang Liu, Tian Hua, Jianbang Han, Chengmei Sun, Limin Xu, Zhongfei Zhang, Zhiming Feng, Yingqian Cai et al. · 2017 · OncoImmunology
  44. C1q and phagocytosis: the perfect complement to a good meal
    Manuel D Galvan, Mallary C. Greenlee‐Wacker, Suzanne S. Bohlson · 2012 · Journal of Leukocyte Biology
  45. Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy
    Xiangru Feng, Weiguo Xu, Jianhua Liu, Di Li, Li Gao, Jianxun Ding, Xuesi Chen · 2020 · 中国科学通报：英文版
  46. Mononuclear phagocyte heterogeneity in cancer: Different subsets and activation states reaching out at the tumor site
    Damya Laoui, Eva Van Overmeire, Kiavash Movahedi, Jan Van den Bossche, Elio Schouppe, Camille Mommer, Alexandros Nikolaou, Yannick Morias, Patrick DE BAETSELIER, Jo A. Van Ginderachter · 2011 · Immunobiology
  47. Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
    Shan-Shan Yin, Feng‐Hou Gao · 2020 · Frontiers in Immunology
  48. Immunosurveillance and immunotherapy of tumors by innate immune cells
    Alexandre Iannello, Thornton W. Thompson, Michele Ardolino, Assaf Marcus, David H. Raulet · 2015 · Current Opinion in Immunology
  49. Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death
    Stefania Di Blasio, Inge M. N. Wortel, Diede A.G. van Bladel, Laura E. de Vries, Tjitske Duiveman‐de Boer, Kuntal Worah, Nienke de Haas, Sonja I. Buschow, I. Jolanda M. de Vries, Carl Gustav Figdor et al. · 2016 · OncoImmunology
  50. CD47‐SIRPα blocking‐based immunotherapy: Current and prospective therapeutic strategies
    Renée Bouwstra, Tom van Meerten, Edwin Bremer · 2022 · Clinical and Translational Medicine
  51. Oxidative Stress–Induced Calreticulin Expression and Translocation: New Insights into the Destruction of Melanocytes
    Yajun Zhang, Ling Liu, Liang Jin, Xiuli Yi, Erle Dang, Yang Yang, Chunying Li, Tianwen Gao · 2013 · Journal of Investigative Dermatology
  52. Myeloid Cell Origins, Differentiation, and Clinical Implications
    Kipp Weiskopf, Peter John Schnorr, Wendy W. Pang, Mark Ping Chao, Akanksha Chhabra, Jun Seita, Mingye Feng, Irving L. Weissman · 2016 · Microbiology Spectrum
  53. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8
    Abdul Qader Sukkurwala, Isabelle Martins, Yidan Wang, Frédéric Schlemmer, Christoph Ruckenstuhl, Michael Durchschlag, Mickaël Michaud, Laura Senovilla, Antonella Sistigu, Yuting Ma et al. · 2013 · Cell Death and Differentiation
  54. Endoplasmic Reticulum Calcium Depletion Impacts Chaperone Secretion, Innate Immunity, and Phagocytic Uptake of Cells
    Larry Robert Peters, Malini Raghavan · 2011 · The Journal of Immunology
  55. Co-delivery of Dihydroartemisinin and Pyropheophorbide-Iron Elicits Ferroptosis to Potentiate Cancer Immunotherapy
    Han, Wenbo, Duan, Xiaopin, Ni, Kaiyuan, Li, Youyou, Chan, Christina, Lin, Wenbin · 2022 · Biomaterials
  56. Harnessing the antitumor potential of macrophages for cancer immunotherapy
    Kristen B. Long, Gregory Lawrence Beatty · 2013 · OncoImmunology
  57. Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm
    Emmanuel Martínez-Ledesma, Roeland G. W. Verhaak, Víctor Treviño · 2015 · Scientific Reports
  58. Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
    Suchismita Mohanty, Ketan Yerneni, Johanna Lena Theruvath, Claus Moritz Graef, Hossein Nejadnik, Olga D. Lenkov, Laura Jean Pisani, Jarrett Rosenberg, Siddhartha S. Mitra, Alejandro Sweet-Cordero et al. · 2019 · Cell Death and Disease
  59. Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
    Jacob P. van Vloten, Samuel Tekeste Workenhe, Sarah K. Wootton, Karen Louise Mossman, Byram W. Bridle · 2018 · The Journal of Immunology
  60. Unexpected therapeutic effects of cisplatin
    Martina Raudenská, Jan Balvan, Michaela Fojtů, Jaromír Gumulec, Michal Masařík · 2019 · Metallomics
  61. Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy
    Yu-Ting Huang, Yuchi Ma, Peng Gao, Zhi Yao · 2017 · Journal of Thoracic Disease
  62. Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
    Erhao Zhang, Jieyi Gu, Hanmei Xu · 2018 · Molecular Cancer
  63. Biomaterial‐Based In Situ Cancer Vaccines
    Bo Yang, Hua Wang · 2023 · Advanced Materials
  64. Smart hydrogel: A new platform for cancer therapy
    Guo Li, Zi-Ming Fu, Haoran Li, Ruibo Wei, Jing Guo, Haiwang Wang, Jian Qi · 2025 · Advances in Colloid and Interface Science
  65. Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments
    Rao Khalid Mehmood · 2014 · Oncology Reviews
  66. Turning cold tumors into hot tumors to ignite immunotherapy
    Yuan‐Tong Liu, Yunlong Wang, Shuo Wang, Jiajun Li, Wei A. He, Xin-Juan Fan, Xiang‐Bo Wan · 2025 · Molecular Cancer
  67. Immunogenic cell death inducers for enhanced cancer immunotherapy
    Yanhua Li, Xiaohan Liu, Xia Zhang, Wei Pan, Na Li, Bo Tang · 2021 · Chemical Communications
  68. Decoding immunogenic cell death from a dendritic cell perspective
    Sophie Janssens, Sofie Rennen, Patrizia Agostinis · 2023 · Immunological Reviews
  69. Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
    María Julia Lamberti, Annunziata Nigro, Fátima María Mentucci, Natalia Belén Rumie Vittar, Vincenzo Casolaro, Jessica Dal Col · 2020 · Pharmaceutics
  70. Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
    Robyn J. Puro, Myriam N. Bouchlaka, Ronald R. Hiebsch, Benjamin J. Capoccia, Michael J. Donio, Pamela Toy Manning, William A. Frazier, Robert W. Karr, Daniel S. Pereira · 2019 · Molecular Cancer Therapeutics
  71. Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
    Haiquan Chen, Chaoqiang Deng, Jian Gao, Jun Wang, Fangqiu Fu, Qiming Wang, Qiming Wang, Shiyue Zhang, Shiyue Zhang, Fanfan Fan et al. · 2025 · Cancer Cell
  72. HIF-1–regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation
    Xiaoxu Liu, Peiling Xie, Na Hao, Miao Zhang, Yang Liu, Peijun Liu, Gregg L. Semenza, Jianjun He, Huimin Zhang · 2021 · Proceedings of the National Academy of Sciences
  73. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
    Bernhard M. Kiss, Nynke S. van den Berg, Robert D. Ertsey, Kelly Marie McKenna, Kathleen E. Mach, Chiyuan Amy Zhang, Jens-Peter Volkmer, Irving L. Weissman, Eben Lloyd Rosenthal, Joseph C. Liao · 2019 · Clinical Cancer Research
  74. Adult stem cells and regenerative medicine—a symposium report
    Jennifer Cable, Elaine V. Fuchs, Irving L. Weissman, Heinrich Jasper, David J. Glass, Thomas A. Rando, Helen M. Blau, Shawon Debnath, Anthony A. Oliva, Sang‐Bum Park et al. · 2019 · Annals of the New York Academy of Sciences
  75. Just eat it: A review of CD47 and SIRP-α antagonism
    Bryan T. Oronsky, Corey Allan Carter, Tony R. Reid, Franck Brinkhaus, Susan Jane Knox · 2020 · Seminars in Oncology
  76. Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models
    Xiuming Liang, Zheyu Niu, Valentina Galli, Nathalie Howe, Ying Heng Zhao, Oscar P. B. Wiklander, Wenyi Zheng, Rim Jawad Wiklander, Giulia Corso, Christopher Davies et al. · 2022 · Journal of Extracellular Vesicles
  77. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
    Aranda, F, Bloy, N, Pesquet, J, Petit, B, Chaba, K, Sauvat, A, Kepp, O, Khadra, N, Enot, D, Pfirschke, C et al. · 2015 · Oncogene
  78. Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed
    Tailong Qu, Baiyong Li, Yifei Wang · 2022 · Biomarker Research
  79. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
    Garg, Abhishek D., Elsen, Sanne, Krysko, Dmitri V., Vandenabeele, Peter, de Witte, Peter, Agostinis, Patrizia · 2015 · Oncotarget
  80. Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
    Dalil Hannani, Antonella Sistigu, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer, Laurence Zitvogel · 2011 · The Cancer Journal
  81. CD47: the next checkpoint target for cancer immunotherapy
    Ridong Feng, Zhao Hai, Jianguo Xu, Chongyang Shen · 2020 · Critical Reviews in Oncology/Hematology
  82. “Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
    Lingjun Xiao, Louqian Zhang, Ciliang Guo, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu · 2024 · 癌症：英文版
  83. Overexpression of Calreticulin Contributes to the Development and Progression of Pancreatic Cancer
    Weiwei Sheng, Chuanping Chen, Ming Dong, Jianping Zhou, Qingfeng Liu, Qi Dong, Feng Li · 2013 · Journal of Cellular Physiology
  84. A siRNA-Assisted Assembly Strategy to Simultaneously Suppress “Self” and Upregulate “Eat-Me” Signals for Nanoenabled Chemo-Immunotherapy
    Yuxi Zhang, Zhenghai Zhang, Senlin Li, Liang Zhao, Dongdong Li, Ziyang Cao, Xiaoding Xu, Xianzhu Yang · 2021 · ACS Nano
  85. Quality assurance of hematopoietic stem cells by macrophages determines stem cell clonality
    Samuel J. Wattrus, Mackenzie L. Smith, Cecília Pessoa Rodrigues, Elliott J. Hagedorn, Ji Wook Kim, Bogdan Budnik, Leonard Ira Zon · 2022 · Science
  86. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
    Irène Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein, Markus Wallwiener, Martina Scharpff, Massimo Saini, Tim Holland‐Letz, Hans‐Peter Sinn et al. · 2014 · Oncotarget
  87. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition
    Rongrong Zheng, Linping Zhao, Chu‐Yu Huang, Hong Bo Cheng, Yang Ni, Zu‐Xiao Chen, Hua Cai, Wei Zhang, Renjiang Kong, Shiying Li · 2023 · ACS Nano
  88. Lifting the innate immune barriers to antitumor immunity
    Carla Vanina Rothlin, Sourav Ghosh · 2020 · Journal for ImmunoTherapy of Cancer
  89. Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
    Lalitha Palanivelu, Ching‐Hsuan Liu, Liang Lin · 2023 · Frontiers in Immunology
  90. Current knowledge of hybrid nanoplatforms composed of exosomes and organic/inorganic nanoparticles for disease treatment and cell/tissue imaging
    Fatemeh Soltanmohammadi, Adel Mahmoudi Gharehbaba, Ali Rajabi Zangi, Khosro Adibkia, Yousef Javadzadeh · 2024 · Biomedicine & Pharmacotherapy
  91. Recent Advances of Gold Compounds in Anticancer Immunity
    Shuang Yue, Miao Luo, Huiguo Liu, Shuang Wei · 2020 · Frontiers in Chemistry
  92. Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy
    Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi · 2021 · Cancers
  93. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
    Christian M. Schürch, Matthias A. Roelli, Stefan Forster, Marie-Hélène Wasmer, Frido K. Bruehl, Renaud Maire, Sergio Di Pancrazio, Marc‐David Ruepp, Roland Giger, Aurel A. Perren et al. · 2019 · Thyroid
  94. Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma
    Xingxing Gao, Hechen Huang, Caixu Pan, Zhibin Mei, Shengyong Yin, Lin Zhou, Shusen Zheng · 2022 · Cancers
  95. Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy
    Jia‐Qi Luo, Rong Liu, Fangman Chen, Jingyang Zhang, Sui-Juan Zheng, Dan Shao, Jin‐Zhi Du · 2023 · ACS Nano
  96. What have we learned about TP53-mutated acute myeloid leukemia?
    Moazzam Shahzad, Muhammad Kashif Amin, Naval Guastad Daver, Mithun Vinod Shah, Devendra Hiwase, Daniel A. Arber, Mohamed A. Kharfan‐Dabaja, Talha Badar · 2024 · Blood Cancer Journal
  97. DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing
    Walter Gottlieb Land, Patrizia Agostinis, Stephan Gasser, Abhishek Dinkarnath Garg, Andreas Linkermann · 2016 · American Journal of Transplantation
  98. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
    Isabel Weinhäuser, Diego A. Pereira‐Martins, Luciana Yamamoto Almeida, Jacobien R. Hilberink, Douglas RA Silveira, Lynn Swun Quek, César Alexander Ortiz Rojas, Cleide L. Araujo, Thiago Mantello Bianco, Antonio Roberto Lucena-Araujo et al. · 2023 · Science Advances
  99. CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
    Ana Carolina Martínez‐Torres, Claire Quiney, Tarik Attout, Héloïse Boullet, Linda Herbi, Laura Vela, Sandrine Barbier, Danielle Château, Élise Chapiro, Florence Nguyen‐Khac et al. · 2015 · PLoS Medicine
  100. In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia
    Kai-Lin Yang, Cheng-Chung Huang, Mau-Shin Chi, Hsin-Chien Chiang, Yu‐Shan Wang, Chien-Chung Hsia, Gábor Andócs, Hsin‐Ell Wang, Kwan‐Hwa Chi · 2016 · Oncotarget